Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort

Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010

(2012) Daniel Parker et al.   MALARIA JOURNAL

Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria

(2011) Gilbert Lefèvre et al.   Annals of the New York Academy of Sciences

Update on genetic markers of quinine resistance in Plasmodium falciparum

(2011) John Okombo et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

(2010) Arjen M Dondorp et al.   LANCET

Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial

(2010) Patrice Piola et al.   LANCET INFECTIOUS DISEASES

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

(2010) Christine Manyando et al.   MALARIA JOURNAL

Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study

(2010) Stephanie Dellicour et al.   PLOS MEDICINE

Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women

(2009) I. Adam et al.   ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY

Sensitive periods for developmental toxicity of orally administered artesunate in the rat

(2008) Tacey E.K. White et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY